PEMFEXY

Serial Number 87365311
606

Registration Progress

Application Filed
Mar 9, 2017
Under Examination
Sep 5, 2017
Approved for Publication
Jul 11, 2017
Published for Opposition
Jul 11, 2017
Registered

Basic Information

Serial Number
87365311
Filing Date
March 9, 2017
Published for Opposition
July 11, 2017
Abandonment Date
October 12, 2020
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Oct 12, 2020
Classes
005

Rights Holder

Eagle Pharmaceuticals Inc.

03
Address
50 Tice Boulevard, Suite 315
Woodcliff Lake, NJ 07677

Ownership History

Eagle Pharmaceuticals Inc.

Original Applicant
03
Woodcliff Lake, NJ

Eagle Pharmaceuticals Inc.

Owner at Publication
03
Woodcliff Lake, NJ

Legal Representation

Attorney
Jacqueline M. Lesser

USPTO Deadlines

All Deadlines Cleared

All 1 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

32 events
Date Code Type Description
Oct 13, 2020 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Oct 12, 2020 ABN6 S ABANDONMENT - NO USE STATEMENT FILED
Mar 14, 2020 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 13, 2020 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL
Mar 13, 2020 EX5G S SOU EXTENSION 5 GRANTED
Mar 4, 2020 EEXT I SOU TEAS EXTENSION RECEIVED
Mar 4, 2020 EXT5 S SOU EXTENSION 5 FILED
Sep 3, 2019 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 30, 2019 EEXT I SOU TEAS EXTENSION RECEIVED
Aug 30, 2019 EXT4 S SOU EXTENSION 4 FILED
Aug 30, 2019 EX4G S SOU EXTENSION 4 GRANTED
Mar 7, 2019 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 5, 2019 EEXT I SOU TEAS EXTENSION RECEIVED
Mar 5, 2019 EXT3 S SOU EXTENSION 3 FILED
Mar 5, 2019 EX3G S SOU EXTENSION 3 GRANTED
Mar 5, 2019 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sep 1, 2018 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 30, 2018 EEXT I SOU TEAS EXTENSION RECEIVED
Aug 30, 2018 EXT2 S SOU EXTENSION 2 FILED
Aug 30, 2018 EX2G S SOU EXTENSION 2 GRANTED
Jan 31, 2018 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 29, 2018 EEXT I SOU TEAS EXTENSION RECEIVED
Jan 29, 2018 EXT1 S SOU EXTENSION 1 FILED
Jan 29, 2018 EX1G S SOU EXTENSION 1 GRANTED
Sep 5, 2017 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jul 11, 2017 PUBO A PUBLISHED FOR OPPOSITION
Jul 11, 2017 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 21, 2017 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 3, 2017 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 2, 2017 DOCK D ASSIGNED TO EXAMINER
Mar 15, 2017 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 13, 2017 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 005
Pharmaceutical preparations for treatment of lung cancer
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
005